4.6 Article

Strong association of the APOA5-1131T>C gene variant and early-onset acute myocardial infarction

Journal

ATHEROSCLEROSIS
Volume 214, Issue 2, Pages 397-403

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.atherosclerosis.2010.11.011

Keywords

Myocardial infarction; Genetics; Association studies; Single nucleotide polymorphisms; APOA5-1131T > C gene variant

Funding

  1. Ministero della Salute [715/2005]
  2. National Institutes of Health [R01 HL087676]
  3. British Heart Foundation [RG08/008]

Ask authors/readers for more resources

Background: Epidemiological studies support the role for a strong genetic component in the occurrence of early-onset myocardial infarction (MI), although the specific genetic variants responsible for familial clustering remain largely unknown. Methods: The Italian study of early-onset MI is a nationwide case-control study involving 1864 case patients <45 years old who were hospitalized for a first MI, and age/sex/place of origin-matched controls (n = 1864). We investigated the association between early-onset MI, lipid levels and 20 single nucleotide polymorphisms (SNPs) in the candidate genes ADIPOQ, APOA5, ALOX5AP, CYBA, IL6, LPL, PECAM1, PLA2G2A and PLA2G7, chosen because of previously reported associations with Coronary Heart Disease (CHD) or with CHD risk factors. Results: Of all the SNPs investigated, APOA5-1131T>C [(rs662799), minor allele frequency 0.084 (95% confidence interval (CI) 0.07-0.09)] alone showed a statistically significant association with risk of early-onset MI (p = 6.7 x 10(-5)), after Bonferroni correction, with a per C allele odds ratio of 1.44 (95% CI 1.23-1.69). In controls, APOA5-1131T>C was significantly associated with raised plasma triglyceride levels (p = 0.001), compared with non-carriers, the per C allele increase being 11.4% (95% CI 4-19%), equivalent to 0.15 mmol/L (95% CI 0.11-0.20 mmol/L). In cases, the association with early MI risk remained statistically significant after adjustment for triglycerides (p = 0.006). Conclusions: The APOA5-1131C allele, associated with higher fasting triglyceride levels, strongly affects the risk for early-onset MI, even after adjusting for triglycerides. This raises the possibility that APOA5-1131T>C may affect the risk of early MI over and above effects mediated by triglycerides. (C) 2010 Published by Elsevier Ireland Ltd.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Hematology

Reduced FVIII recovery associated with anti-FVIII PEG antibodies after BNT162b2 SARS-CoV-2 vaccination

Carla Valsecchi, Roberta Gualtierotti, Sara Arcudi, Alessandro Ciavarella, Lucia Schiavone, Cristina Novembrino, Simona Maria Siboni, Pier Mannuccio Mannucci, Flora Peyvandi

BLOOD ADVANCES (2023)

Article Hematology

Recombinant factor VIII Fc fusion protein for first-time immune tolerance induction: final results of the verITI-8 study

Lynn Malec, An Van Damme, Anthony K. C. Chan, Mariya Spasova, Nisha Jain, Charlotte Sensinger, Jennifer Dumont, Stefan Lethagen, Manuel Carcao, Flora Peyvandi

Summary: Inhibitor development remains a major challenge in factor VIII replacement therapy. The verITI-8 study evaluated the use of a recombinant FVIII Fc fusion protein (rFVIIIFc) for immune tolerance induction in males with severe hemophilia A and high-titer inhibitors. The study showed that rFVIIIFc achieved tolerization in a significant number of patients within a short time period, and adverse events were generally well tolerated.

BLOOD (2023)

Editorial Material Gastroenterology & Hepatology

Liver-related aspects of gene therapy for haemophilia: Call to action for collaboration between haematologists and hepatologists

Wolfgang Miesbach, Graham R. Foster, Flora Peyvandi

JOURNAL OF HEPATOLOGY (2023)

Review Hematology

Prevalence of selected bleeding and thrombotic events in persons with hemophilia versus the general population: A scoping review

Amy D. Shapiro, Brandon M. Hardesty, Flora Peyvandi, Alfonso Iorio

Summary: Life expectancy for persons with hemophilia has increased due to advances in treatment, but they are now more likely to be affected by conditions associated with aging. This study analyzed the prevalence of bleeding and thrombotic events in hemophilia populations compared to the general population. The results showed consistently higher rates of bleeding events in hemophilia populations, while the prevalence of arterial thrombosis varied.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2023)

Article Hematology

Prophylaxis with recombinant von Willebrand factor in patients with type 3 von Willebrand disease: Results of a post hoc analysis from a phase 3 trial

Frank W. G. Leebeek, Flora Peyvandi, Andreas Tiede, Giancarlo Castaman, Miguel Escobar, Michael Wang, Bulent Zulfikar, Sophie Susen, Wolfgang Miesbach, Scarlett Wang, Yi Wang, Jingmei Zhang, Gulden Ozen

Summary: This study demonstrates the efficacy and safety of recombinant von Willebrand factor (rVWF) prophylaxis in patients with type 3 von Willebrand disease (VWD). The results show that rVWF prophylaxis significantly reduces bleeding rates in patients previously treated with on-demand VWF therapy or plasma-derived VWF prophylaxis. These findings highlight the effectiveness and safety of rVWF prophylaxis in type 3 VWD patients.

EUROPEAN JOURNAL OF HAEMATOLOGY (2023)

Article Hematology

Diagnostic utility of bleeding assessment tools in congenital fibrinogen deficiencies

Samin Mohsenian, Omid Seidizadeh, Roberta Palla, Mohammad Jazebi, Azita Azarkeivan, Somayeh Moazezi, Mohammad Reza Baghaipour, Marzia Menegatti, Flora Peyvandi

Summary: This study compared the effectiveness of ISTH-BAT and EN-RBD-BSS in identifying patients with CFDs. Both tools were found to have a certain level of accuracy, and showed significant correlation with Fg:C for patients with quantitative deficiencies.

HAEMOPHILIA (2023)

Review Hematology

International Council for Standardization in Haematology recommendations for laboratory measurement of factor VIII and FIX type I inhibitors

Piet Meijer, Flora Peyvandi, Guy Young, Rajiv Pruthi, Silmara de Lima Montalvao, Steve Kitchen

Summary: This guidance document provides recommendations on the measurement of factor VIII (FVIII) and factor IX (FIX) inhibitors, including screening, assay principle, sample and testing requirements, interpretation, quality assurance, interferences, and recent developments. It focuses on standardizing the laboratory measurement of FVIII and FIX type I inhibitors based on published data and expert opinion.

INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2023)

Article Medicine, General & Internal

Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A

J. Mahlangu, R. Kaczmarek, A. von Drygalski, S. Shapiro, S. -C. Chou, M. C. Ozelo, G. Kenet, F. Peyvandi, M. Wang, B. Madan, N. S. Key, M. Laffan, A. L. Dunn, J. Mason, D. V. Quon, E. Symington, A. D. Leavitt, J. Oldenburg, H. Chambost, M. T. Reding, K. Jayaram, H. Yu, R. Mahajan, K. -M. Chavele, D. B. Reddy, J. Henshaw, T. M. Robinson, W. Y. Wong, S. W. Pipe

Summary: This study demonstrates the long-term effectiveness and safety of valoctocogene roxaparvovec therapy in reducing bleeding events in men with severe hemophilia A. The pharmacokinetic modeling suggests a half-life of 123 weeks for the transgene-derived factor VIII production system. Models also indicate a similar relationship between factor VIII activity and bleeding episodes as observed in individuals with mild-to-moderate hemophilia A using epidemiologic data.

NEW ENGLAND JOURNAL OF MEDICINE (2023)

Article Multidisciplinary Sciences

Improving stress management, anxiety, and mental well-being in medical students through an online Mindfulness-Based Intervention: a randomized study

Teresa Fazia, Francesco Bubbico, Andrea Nova, Chiara Buizza, Herald Cela, Davide Iozzi, Beril Calgan, Federica Maggi, Valentina Floris, Irene Sutti, Salvatore Bruno, Alberto Ghilardi, Luisa Bernardinelli

Summary: The pressures and responsibilities of medical school have a negative impact on the personal wellbeing of medical students, leading to high levels of anxiety, emotional discomfort, and stress. This study evaluated the effectiveness of a comprehensive Mindfulness-Based Intervention in reducing this burden. The intervention, which included meditation classes, dietary advice, and yoga sessions, was found to significantly reduce perceived stress, improve mental wellbeing and emotional regulation, enhance resilience, decrease mind-wandering, improve attentional control, and reduce overall distress.

SCIENTIFIC REPORTS (2023)

Article Medicine, General & Internal

The Association between Dysnatraemia during Hospitalisation and Post-COVID-19 Mental Fatigue

Gerardo Salvato, Elvira Inglese, Teresa Fazia, Francesco Crottini, Daniele Crotti, Federica Valentini, Giulio Palmas, Alessandra Bollani, Stefania Basilico, Martina Gandola, Giorgio Gelosa, Davide Gentilini, Luisa Bernardinelli, Andrea Stracciari, Francesco Scaglione, Elio Clemente Agostoni, Gabriella Bottini

Summary: COVID-19 recovery may lead to short- and long-term cognitive failures, with controversial underlying risk factors. This study investigated the association between disease course severity, sex at birth, and the odds of persistent cognitive failures after recovery. Results showed that females with a mild course of COVID-19 had a higher risk of persistent mental fatigue, particularly related to electrolyte imbalance during hospitalization. These findings have important implications for the clinical management of hospitalized COVID-19 patients, emphasizing the need to monitor electrolyte levels, especially in females with mild disease.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Hematology

A comparative study in patients with type 2 von Willebrand disease using 4 different platelet-dependent von Willebrand factor assays

Paola Colpani, Luciano Baronciani, Francesca Stufano, Giovanna Cozzi, Marco Boscarino, Maria Teresa Pagliari, Eugenia Biguzzi, Flora Peyvandi

Summary: This study evaluated four different assays to diagnose and detect various von Willebrand disease (VWD) variants. The VWF:GPIbM-automated assay was the most effective in diagnosing type 2B, while the VWF:RCo assays were the most effective in detecting type 2M and 2M/2A variants. The VWF:GPIbM ELISA overestimated the activity of type 2B patients lacking high-molecular-weight multimers (HMWM). Using a VWF activity/VWF:antigen ratio cut-off of 0.70 reduced the number of misdiagnosed patients by half.

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2023)

Article Hematology

Accreditation model of European Haemophilia Centres in the era of novel treatments and gene therapy

Ana Boban, Fariba Baghaei, Fijnvandraat Karin, Robert Klamroth, Wolfgang Miesbach, David Stephensen, Mary Kavanagh, Declan Noone, Miguel Crato, Flora Peyvandi

Summary: This article introduces the background and purpose of international certification of haemophilia centres in Europe, as well as the methods and results of establishing a new accreditation protocol.

HAEMOPHILIA (2023)

Article Hematology

Psychological and cognitive factors involved in decision-making process of haemophilia carriers in reproductive choices

Ilaria Cutica, Mimosa Mortarino, Isabella Garagiola, Gabriella Pravettoni, Flora Peyvandi

Summary: This study found that the beliefs and emotions, as well as cognitive factors such as decision-making style, risk perception, coping strategies, and need for cognitive closure, may influence the reproductive decisions of haemophilia carriers (HCs). HCs with negative early-life experiences and high concerns for their children's health, as well as logical reasoning, active coping style, and high need for certainty, tend to choose diagnostic prenatal tests. Therefore, this study highlights the influence of negative early-life experiences and cognitive factors on the prenatal test choice of HCs.

HAEMOPHILIA (2023)

Article Hematology

Minimum factor VIII levels to prevent joint bleeding in mild hemophilia A

Pasquale Agosti, Simona Maria Siboni, Sara Scardo, Adriana Torri, Roberta Gualtierotti, Flora Peyvandi

Summary: This study aimed to identify the minimum FVIII levels necessary to prevent joint bleeds in patients with hemophilia A. The findings suggest important implications for the design of prophylactic therapies for moderate and severe hemophilia A.

BLOOD ADVANCES (2023)

Letter Hematology

Comment on: A comparative study in type 2 von Willebrand disease patients using four different platelet-dependent von Willebrand factor assays

Paola Colpani, Luciano Baronciani, Giovanna Cozzi, Maria Teresa Pagliari, Eugenia Biguzzi, Flora Peyvandi

RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2023)

No Data Available